PL367702A1 - Kombinacja taksanu i cyklino-zależnej kinazy - Google Patents

Kombinacja taksanu i cyklino-zależnej kinazy

Info

Publication number: PL367702A1
Authority: PL; Poland
Prior art keywords: taxane; cyclin; combination; dependent kinase; kinase
Prior art date: 2001-03-23

Application number

PL02367702A

Other languages

English (en)

Other versions

PL206118B1 (pl

Inventor

Marie-Christine Bissery

Original Assignee

Aventis Pharma S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-23

Filing date

2002-03-22

Publication date

2005-03-07

2002-03-22 Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.

2005-03-07 Publication of PL367702A1 publication Critical patent/PL367702A1/pl

2010-07-30 Publication of PL206118B1 publication Critical patent/PL206118B1/pl

Links

102000003903 Cyclin-dependent kinases Human genes 0.000 title 1
108090000266 Cyclin-dependent kinases Proteins 0.000 title 1
229940123237 Taxane Drugs 0.000 title 1
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL367702A 2001-03-23 2002-03-22 Kombinacja farmaceutyczna wykazująca synergizm terapeutyczny in vivo w leczeniu chorób nowotworowych PL206118B1 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US27794801P	2001-03-23	2001-03-23
US30269201P	2001-07-05	2001-07-05
US33491601P	2001-12-04	2001-12-04
PCT/EP2002/004083 WO2002076484A2 (en)	2001-03-23	2002-03-22	Combination of a taxane and a cyclin-dependent kinase inhibitor

Publications (2)

Publication Number	Publication Date
PL367702A1 true PL367702A1 (pl)	2005-03-07
PL206118B1 PL206118B1 (pl)	2010-07-30

Family

ID=27402954

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL367702A PL206118B1 (pl)	2001-03-23	2002-03-22	Kombinacja farmaceutyczna wykazująca synergizm terapeutyczny in vivo w leczeniu chorób nowotworowych

Country Status (33)

Country	Link
US (2)	US20020182204A1 (pl)
EP (1)	EP1372652B1 (pl)
JP (1)	JP2004521140A (pl)
KR (1)	KR100879712B1 (pl)
CN (1)	CN1498107A (pl)
AR (1)	AR034222A1 (pl)
AT (1)	ATE395917T1 (pl)
AU (1)	AU2002312815B2 (pl)
BR (1)	BR0208221A (pl)
CA (1)	CA2441441C (pl)
CY (1)	CY1110449T1 (pl)
CZ (1)	CZ301423B6 (pl)
DE (1)	DE60226710D1 (pl)
DK (1)	DK1372652T3 (pl)
EA (1)	EA007815B1 (pl)
ES (1)	ES2305253T3 (pl)
HR (1)	HRPK20030766B3 (pl)
HU (1)	HU229258B1 (pl)
IL (2)	IL158058A0 (pl)
ME (1)	MEP16408A (pl)
MX (1)	MXPA03007743A (pl)
NO (1)	NO332441B1 (pl)
NZ (1)	NZ527655A (pl)
PE (1)	PE20020907A1 (pl)
PL (1)	PL206118B1 (pl)
PT (1)	PT1372652E (pl)
RS (1)	RS50681B (pl)
SI (1)	SI1372652T1 (pl)
SK (1)	SK287481B6 (pl)
TW (1)	TWI355935B (pl)
UY (1)	UY27220A1 (pl)
WO (1)	WO2002076484A2 (pl)
ZA (1)	ZA200307381B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60313754T2 (de) *	2002-03-06	2008-01-24	The Medical Research and Education Trust, San Diego	Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
WO2004035034A2 (en) *	2002-10-16	2004-04-29	Ilex Products, Inc.	Clofarabine and taxane chemotherapy combination
BR0316010A (pt) *	2002-11-06	2005-09-13	Cyclacel Ltd	Combinação
EA014231B1 (ru) *	2006-02-10	2010-10-29	НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л.	Комбинации, включающие ингибитор cdk и антитело фактора роста или антимитотик
AU2011330733A1 (en) *	2010-11-19	2013-06-06	Piramal Enterprises Limited	Pharmaceutical combination of paclitaxel and a CDK inhibitor
WO2012131399A1 (en) *	2011-04-01	2012-10-04	Astrazeneca Ab	Therapeutic treatment
PT2785349T (pt)	2011-11-30	2019-12-11	Astrazeneca Ab	Tratamento combinado de cancro
AU2013204533B2 (en)	2012-04-17	2017-02-02	Astrazeneca Ab	Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601675B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) *	1990-11-23	1992-07-08	Rhone Poulenc Rorer Sa	Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) *	1992-11-10	1995-04-14	Rhone Poulenc Rorer Sa	Compositions antitumorales contenant des dérivés du taxane.
EP0888458A4 (en) *	1996-02-20	2004-05-06	Sloan Kettering Institutefor C	COMBINATION OF PKC INHIBITORS AND THERAPEUTIC AGENTS FOR TREATING CANCER

2002
- 2002-03-21 US US10/101,947 patent/US20020182204A1/en not_active Abandoned
- 2002-03-21 UY UY27220A patent/UY27220A1/es not_active Application Discontinuation
- 2002-03-22 RS YUP-695/03A patent/RS50681B/sr unknown
- 2002-03-22 DE DE60226710T patent/DE60226710D1/de not_active Expired - Lifetime
- 2002-03-22 MX MXPA03007743A patent/MXPA03007743A/es active IP Right Grant
- 2002-03-22 AU AU2002312815A patent/AU2002312815B2/en not_active Ceased
- 2002-03-22 WO PCT/EP2002/004083 patent/WO2002076484A2/en not_active Ceased
- 2002-03-22 TW TW091105567A patent/TWI355935B/zh not_active IP Right Cessation
- 2002-03-22 HR HR20030766A patent/HRPK20030766B3/xx not_active IP Right Cessation
- 2002-03-22 PT PT02737950T patent/PT1372652E/pt unknown
- 2002-03-22 PL PL367702A patent/PL206118B1/pl not_active IP Right Cessation
- 2002-03-22 SI SI200230711T patent/SI1372652T1/sl unknown
- 2002-03-22 IL IL15805802A patent/IL158058A0/xx unknown
- 2002-03-22 ME MEP-164/08A patent/MEP16408A/xx unknown
- 2002-03-22 NZ NZ527655A patent/NZ527655A/xx not_active IP Right Cessation
- 2002-03-22 JP JP2002574997A patent/JP2004521140A/ja active Pending
- 2002-03-22 HU HU0303589A patent/HU229258B1/hu not_active IP Right Cessation
- 2002-03-22 AR ARP020101061A patent/AR034222A1/es unknown
- 2002-03-22 EA EA200301053A patent/EA007815B1/ru not_active IP Right Cessation
- 2002-03-22 PE PE2002000230A patent/PE20020907A1/es not_active Application Discontinuation
- 2002-03-22 AT AT02737950T patent/ATE395917T1/de active
- 2002-03-22 CA CA002441441A patent/CA2441441C/en not_active Expired - Fee Related
- 2002-03-22 ES ES02737950T patent/ES2305253T3/es not_active Expired - Lifetime
- 2002-03-22 KR KR1020037012338A patent/KR100879712B1/ko not_active Expired - Fee Related
- 2002-03-22 EP EP02737950A patent/EP1372652B1/en not_active Expired - Lifetime
- 2002-03-22 SK SK1169-2003A patent/SK287481B6/sk not_active IP Right Cessation
- 2002-03-22 BR BR0208221-7A patent/BR0208221A/pt not_active Application Discontinuation
- 2002-03-22 CN CNA028070380A patent/CN1498107A/zh active Pending
- 2002-03-22 CZ CZ20032551A patent/CZ301423B6/cs not_active IP Right Cessation
- 2002-03-22 DK DK02737950T patent/DK1372652T3/da active
2003
- 2003-09-16 NO NO20034124A patent/NO332441B1/no not_active IP Right Cessation
- 2003-09-22 IL IL158058A patent/IL158058A/en not_active IP Right Cessation
- 2003-09-22 ZA ZA2003/07381A patent/ZA200307381B/en unknown
2006
- 2006-01-27 US US11/341,840 patent/US20060128640A1/en not_active Abandoned
2008
- 2008-08-11 CY CY20081100843T patent/CY1110449T1/el unknown

Also Published As

Publication number	Publication date
NO332441B1 (no)	2012-09-17
PT1372652E (pt)	2008-07-24
IL158058A (en)	2010-02-17
TWI355935B (en)	2012-01-11
CN1498107A (zh)	2004-05-19
HU229258B1 (en)	2013-10-28
ES2305253T3 (es)	2008-11-01
WO2002076484A2 (en)	2002-10-03
HUP0303589A3 (en)	2007-05-02
MXPA03007743A (es)	2004-11-12
RS50681B (sr)	2010-06-30
CY1110449T1 (el)	2015-04-29
BR0208221A (pt)	2004-03-02
EA007815B1 (ru)	2007-02-27
SI1372652T1 (sl)	2008-10-31
SK287481B6 (sk)	2010-11-08
WO2002076484A3 (en)	2003-01-03
EA200301053A1 (ru)	2004-02-26
UY27220A1 (es)	2002-09-30
KR100879712B1 (ko)	2009-01-22
HUP0303589A2 (hu)	2004-03-01
CZ301423B6 (cs)	2010-02-24
CA2441441C (en)	2009-05-26
EP1372652B1 (en)	2008-05-21
SK11692003A3 (sk)	2004-03-02
AU2002312815B2 (en)	2006-08-24
AR034222A1 (es)	2004-02-04
US20060128640A1 (en)	2006-06-15
CZ20032551A3 (en)	2004-07-14
JP2004521140A (ja)	2004-07-15
DE60226710D1 (de)	2008-07-03
NZ527655A (en)	2006-03-31
ATE395917T1 (de)	2008-06-15
PL206118B1 (pl)	2010-07-30
ZA200307381B (en)	2005-03-30
CA2441441A1 (en)	2002-10-03
IL158058A0 (en)	2004-03-28
KR20030086318A (ko)	2003-11-07
US20020182204A1 (en)	2002-12-05
DK1372652T3 (da)	2008-09-22
NO20034124L (no)	2003-09-16
HRPK20030766B3 (en)	2006-11-30
MEP16408A (en)	2010-10-10
YU69503A (sh)	2006-08-17
PE20020907A1 (es)	2002-12-19
NO20034124D0 (no)	2003-09-16
HRP20030766A2 (en)	2005-06-30
EP1372652A2 (en)	2004-01-02

Legal Events

Date	Code	Title	Description
2015-05-29	LAPS	Decisions on the lapse of the protection rights	Effective date: 20140322

Publication	Publication Date	Title
MXPA03006420A (es)	2003-10-15	Diaminotiazoles.
SG111920A1 (en)	2005-06-29	Authentication of electronic documents
AU2002332749A1 (en)	2003-03-18	Package with integrated inductor and/or capacitor
GB0121789D0 (en)	2001-10-31	Electronic paymetn authorisation
PL369867A1 (pl)	2005-05-02	Bicykliczne pochodne oksopirydyny i oksopirymidyny
EP1390052A4 (en)	2008-10-08	INHIBITION OF JUN KINASE
PL368321A1 (pl)	2005-03-21	Zastosowanie cystationiny
SG100745A1 (en)	2003-12-26	Ceramic composition and ceramic capacitor
EP1392317A4 (en)	2005-10-19	SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
GB0126889D0 (en)	2002-01-02	Compounds and their uses
GB0123657D0 (en)	2001-11-21	Worktool
GB2376928B (en)	2003-04-30	Personal hoverplane having four tiltmotors
HUP0500734A3 (en)	2005-12-28	Use of 2-alkoxyphenyl-substituted imidazotriazinones
HUP0303589A3 (en)	2007-05-02	Combination of a taxane and a cyclin-dependent kinase inhibitor
PL367639A1 (pl)	2005-03-07	Nowy związek heterocykliczny i jego zastosowanie w medycynie
IL158239A0 (en)	2004-05-12	Zonisamide intermediate and synthesis
EP1381061A4 (en)	2008-10-29	INDUCTANCE ELEMENT AND HOUSING
GB0115234D0 (en)	2001-08-15	Electronic authorisation
HUP0401162A3 (en)	2007-05-02	Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
IL161608A0 (en)	2004-09-27	Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
EP1421101A4 (en)	2005-01-19	P-GLYCOPROTEINS AND THEIR USES
EP1367123A4 (en)	2005-10-12	NEUROTONIN AND ITS USE
IL156839A0 (en)	2004-02-08	Use of chromanes
EP1392460A4 (en)	2009-11-04	AMINOSILANOL HYDROFLUORIDES AND THEIR USE
ZA200305379B (en)	2004-10-11	Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase.